Laura Orlando, Managing Partner in our Milan office has been interviewed by Managing IP (MIP), regarding which city will replace London as the site of the central division seat for the UPC dealing with pharmaceutical matters.

Laura’s comments include:

The question of which city, if any, will replace London is ultimately a political one, and it will require a diplomatic effort on the part of the successful candidate’s government to secure the seat.

MIP reports that, “in Orlando’s opinion, the Italian state’s historic lack of interest in IP represents a “huge risk” to Milan’s candidacy” and that “the danger, she argues, is that any lack of engagement from the Italian government will simply result in Munich and Paris – the two current hosts – remaining as the only two central division seats”.

You can read the full article on the Managing IP website here.